Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Johanna Stachelscheid"'
Autor:
Till Braun, Annika Dechow, Gregor Friedrich, Michael Seifert, Johanna Stachelscheid, Marco Herling
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
T-cell prolymphocytic leukemia (T-PLL) is the most common mature T-cell leukemia. It is a typically aggressively growing and chemotherapy-resistant malignancy with a poor prognosis. T-PLL cells resemble activated, post-thymic T-lymphocytes with memor
Externí odkaz:
https://doaj.org/article/49ba8721712f4235aa02df60ddb8df88
Autor:
Qu Jiang, Johanna Stachelscheid, Johannes Bloehdorn, Alicja Pacholewska, Christoph Markus Aszyk, Francien Grotenhuijs, Tony Andreas Müller, Ozlem Onder, Prerana Wagle, Carmen Diana Herling, Maria Kleppe, Zhefang Wang, Kevin R. Coombes, Sandra Robrecht, Priya S. Dalvi, Bianca Andra Lungu, Petra Mayer, Lynne V. Abruzzo, Janine Altmüller, Birgit Sybille Gathof, Thorsten Persigehl, Kirsten Fischer, Billy Michael Chelliah Jebaraj, Hugh Young Rienhoff, Rupert C. Ecker, Yue Zhao, Christiane Josephine Bruns, Stephan Stilgenbauer, Kojo S. J. Elenitoba-Johnson, Michael Hallek, Michal R. Schweiger, Margarete Odenthal, Elena Vasyutina, Marco Herling
Publikováno v:
Blood.
In chronic lymphocytic leukemia (CLL), epigenetic alterations are considered to centrally shape the transcriptional signatures that drive disease evolution and that underlie its biological and clinical subsets. Characterizations of epigenetic regulat
Autor:
Marco Herling, Alexandra Schrader, Stefan Hüttelmaier, Daniel Auguin, Michael Hallek, Janine Altmüller, Birgit Gathof, Marek Franitza, Katharina Ommer, Markus Glaß, Linus Wahnschaffe, Tony Andreas Müller, Moritz Otte, Sebastian Oberbeck, Nadine Bley, Johanna Stachelscheid, Till Braun
Supplementary Table from Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29c141b2d3e7d1971ae177a13a3a23f6
https://doi.org/10.1158/0008-5472.22431076.v1
https://doi.org/10.1158/0008-5472.22431076.v1
Autor:
Marco Herling, Alexandra Schrader, Stefan Hüttelmaier, Daniel Auguin, Michael Hallek, Janine Altmüller, Birgit Gathof, Marek Franitza, Katharina Ommer, Markus Glaß, Linus Wahnschaffe, Tony Andreas Müller, Moritz Otte, Sebastian Oberbeck, Nadine Bley, Johanna Stachelscheid, Till Braun
Supplementary Figure from Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::029066d721fddd13077ebd47940ba924
https://doi.org/10.1158/0008-5472.22431088
https://doi.org/10.1158/0008-5472.22431088
Autor:
Marco Herling, Alexandra Schrader, Stefan Hüttelmaier, Daniel Auguin, Michael Hallek, Janine Altmüller, Birgit Gathof, Marek Franitza, Katharina Ommer, Markus Glaß, Linus Wahnschaffe, Tony Andreas Müller, Moritz Otte, Sebastian Oberbeck, Nadine Bley, Johanna Stachelscheid, Till Braun
T-cell prolymphocytic leukemia (T-PLL) is a chemotherapy-refractory T-cell malignancy with limited therapeutic options and a poor prognosis. Current disease concepts implicate TCL1A oncogene-mediated enhanced T-cell receptor (TCR) signaling and aberr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83dd110a0b3042fa1db8767a1a42fc5d
https://doi.org/10.1158/0008-5472.c.6513796
https://doi.org/10.1158/0008-5472.c.6513796
Autor:
Marco Herling, Alexandra Schrader, Stefan Hüttelmaier, Daniel Auguin, Michael Hallek, Janine Altmüller, Birgit Gathof, Marek Franitza, Katharina Ommer, Markus Glaß, Linus Wahnschaffe, Tony Andreas Müller, Moritz Otte, Sebastian Oberbeck, Nadine Bley, Johanna Stachelscheid, Till Braun
Supplementary Data from Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20848ccac394de23658001a58486f8dd
https://doi.org/10.1158/0008-5472.22431091
https://doi.org/10.1158/0008-5472.22431091
Autor:
Till Braun, Johanna Stachelscheid, Nadine Bley, Sebastian Oberbeck, Moritz Otte, Tony Andreas Müller, Linus Wahnschaffe, Markus Glaß, Katharina Ommer, Marek Franitza, Birgit Gathof, Janine Altmüller, Michael Hallek, Daniel Auguin, Stefan Hüttelmaier, Alexandra Schrader, Marco Herling
Publikováno v:
Cancer Research. 82:1818-1831
T-cell prolymphocytic leukemia (T-PLL) is a chemotherapy-refractory T-cell malignancy with limited therapeutic options and a poor prognosis. Current disease concepts implicate TCL1A oncogene-mediated enhanced T-cell receptor (TCR) signaling and aberr
Autor:
Moritz Otte, Johanna Stachelscheid, Markus Glaß, Linus Wahnschaffe, Qu Jiang, Waseem Lone, Aleksandr Ianevski, Tero Aittokallio, Javeed Iqbal, Michael Hallek, Stefan Hüttelmaier, Alexandra Schrader, Till Braun, Marco Herling
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2527
T-prolymphocytic leukemia (T-PLL) is a rare and mature T-cell malignancy with characteristic chemotherapy-refractory behavior and a poor prognosis. Molecular concepts of disease development have been restricted to protein-coding genes. Recent global
Publikováno v:
Cancers
Cancers, Vol 13, Iss 5455, p 5455 (2021)
Cancers, Vol 13, Iss 5455, p 5455 (2021)
Simple Summary T-cell leukemia/lymphoma 1A (TCL1A) is a proto-oncogene that is mainly expressed in embryonic and fetal tissues, as well as in some lymphatic cells. It is frequently overexpressed in a variety of T- and B-cell lymphomas and in some sol